, Volume 19, Issue 6, pp 322–323 | Cite as

Gestione clinica e decisioni terapeutiche appropriate nei macroadenomi ipofisari resistenti

  • Salvatore CannavòEmail author


  1. 1.
    Salenave S, Ancelle D, Bahougne T et al. (2015) Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J Clin Endocrinol Metab 100:1177–1186 CrossRefPubMedGoogle Scholar
  2. 2.
    Beckers A, Aaltonen LA, Daly AF, Karhu A (2013) Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 34:239–277 CrossRefPubMedGoogle Scholar
  3. 3.
    Korbonits M, Storr H, Kumar AV (2012) Familial pituitary adenomas—who should be tested for AIP mutations? Clin Endocrinol 77:351–356 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Dipartimento di Patologia Umana dell’Adulto e dell’Età Evolutiva “G. Barresi”Università di MessinaMessinaItalia

Personalised recommendations